|
|
|
41
|
0212BQ
|
IMIPENEM/CILASTATIN |500MG INJ (LDP) CILASTATIN|IMIPENEM
|
CILASTATIN|IMIPENEM
|
IMIPENEM/CILASTATIN
|
1 DOSE
|
BQ
|
27.56
|
27.56
|
VIAL
|
|
VIAL
|
LDP
|
LABDHI PHARMA
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
08120708
|
CARBAPENEMS
|
2024-04-03
|
2026-03-31
|
|
INJECTION
|
|
CARBAPENEMS
|
2024-04-03
|
|
|
|
42
|
0212BQ
|
CILASTATIN|IMIPENEM 500MG|500MG INJ (LDP)
|
CILASTATIN|IMIPENEM
|
CILASTATIN|IMIPENEM
|
500MG VIAL
|
BQ
|
23.87
|
23.87
|
VIAL
|
0
|
VIAL
|
LDP
|
LABDHI PHARMA
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
08120708
|
CARBAPENEMS
|
2026-04-01
|
|
|
IV
|
0
|
CARBAPENEMS
|
|
|
|
|
40
|
0225H
|
LACLOXA 500MG INJ (LDP/AHI) CLOXACILLIN
|
CLOXACILLIN
|
LACLOXA
|
500MG VIAL
|
B
|
15.41
|
15.41
|
INJECTION
|
0
|
VIAL
|
LDP
|
LABDHI PHARMA
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
081216
|
PENICILLINS
|
2022-04-01
|
2022-09-30
|
|
IV
|
6
|
ANTI-INFECTIVE AGENTS
|
2022-03-29
|
|
|
|
41
|
0225M
|
LACLOXA 500MG INJ (LDP) CLOXACILLIN (B)
|
CLOXACILLIN
|
LACLOXA
|
10X5ML
|
B
|
62.79
|
6.2793
|
VIAL
|
56
|
BOX
|
LDP
|
LABDHI PHARMA
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
081216
|
PENICILLINS
|
2024-04-01
|
2026-03-31
|
|
IV
|
6
|
PENICILLINS
|
|
|
|
|
40
|
0302AA
|
LACLIDA 150MG/ML INJ (LDP/AHI) CLINDAMYCIN PH
|
CLINDAMYCIN PHOSPHATE
|
LACLIDA
|
10X4ML
|
BQ
|
79.86
|
7.99
|
INJECTION
|
0
|
AMP
|
LDP
|
LABDHI PHARMA
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
08122820
|
LINCOMYCINS
|
2022-04-01
|
2024-03-31
|
|
IV
|
6
|
ANTI-INFECTIVE AGENTS
|
|
|
|
|
40
|
0314B
|
FUSIDIC ACID DRESSING 1% (LDP/AHI)
|
FUSIDIC ACID
|
FUSIDIC ACID DRESSING
|
10'S
|
A
|
19.14
|
19.14
|
|
10
|
BOX
|
LDP
|
LABDHI PHARMA
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
840404
|
ANTIBIOTICS TOPICAL
|
2022-04-01
|
2024-03-31
|
|
TOPICAL
|
0
|
SKIN-MUCOUS MEMBRANE PREPARATIONS
|
|
|
|
|
41
|
0314B
|
FUSIDIC ACID DRESSING 1% DRESSING (LDP)
|
FUSIDIC ACID
|
FUSIDIC ACID DRESSING
|
10'S
|
A
|
18.97
|
1.8974
|
EACH
|
10
|
BOX
|
LDP
|
LABDHI PHARMA
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
840404
|
ANTIBIOTICS TOPICAL
|
2024-04-01
|
2026-03-31
|
|
TOPICAL
|
6
|
ANTIBIOTICS TOPICAL
|
|
|
|
|
42
|
0314B
|
FUSIDIC ACID DRESSING 1% DRESSING (LDP)
|
FUSIDIC ACID
|
FUSIDIC ACID DRESSING
|
10'S
|
A
|
18.97
|
1.90
|
EACH
|
10
|
BOX
|
LDP
|
LABDHI PHARMA
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
840404
|
ANTIBIOTICS TOPICAL
|
2026-04-01
|
|
Add to Contract as Cat A
|
TOPICAL
|
6
|
ANTIBIOTICS TOPICAL
|
2026-03-18
|
|
|
|
40
|
0472A
|
DAPSONE 100MG TAB (LDP/AHI)
|
DAPSONE
|
DAPSONE
|
100'S
|
A
|
32.62
|
0.33
|
TABLET
|
90
|
TAB
|
LDP
|
LABDHI PHARMA
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
081692
|
ANTIMYCOBACTERIALS, MISCELLANEOUS
|
2022-04-01
|
2024-03-31
|
|
Oral
|
6
|
ANTI-INFECTIVE AGENTS
|
|
|
|
|
41
|
0472A
|
DAPSONE 100MG TAB (LDP)
|
DAPSONE
|
DAPSONE
|
100'S
|
A
|
32.62
|
0.3262
|
TAB
|
90
|
BOX
|
LDP
|
LABDHI PHARMA
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
081692
|
ANTIMYCOBACTERIALS, MISCELLANEOUS
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
6
|
ANTIMYCOBACTERIALS, MISCELLANEOUS
|
|
|
|
|
40
|
0692J
|
LASTIGMINE 2.5MG/ML INJ (LDP/AHI)
|
NEOSTIGMINE
|
LASTIGMINE
|
5X1ML
|
BQ
|
16.99
|
3.40
|
INJECTION
|
0
|
AMP
|
LDP
|
LABDHI PHARMA
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
1204
|
PARASYMPATHOMIMETIC (CHOLINERGIC) AGENTS
|
2022-04-01
|
2022-09-30
|
|
IV
|
0
|
AUTONOMIC DRUGS
|
2022-03-29
|
|
|
|
40
|
0694C
|
LASTIGMINE PLUS 2.5MG/ML INJ (LDP/AHI)
|
NEOSTIGMINE
|
LASTIGMINE PLUS
|
5X5ML
|
BQ
|
26.10
|
5.22
|
INJECTION
|
0
|
AMP
|
LDP
|
LABDHI PHARMA
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
1204
|
PARASYMPATHOMIMETIC (CHOLINERGIC) AGENTS
|
2022-04-01
|
2022-09-30
|
|
IV
|
0
|
AUTONOMIC DRUGS
|
2022-03-29
|
|
|
|
41
|
0694C
|
LASTIGMINE PLUS 2.5MG/ML INJ (LDP) (BQ)
|
NEOSTIGMINE
|
LASTIGMINE PLUS
|
5X5ML
|
BQ
|
29.58
|
5.9151
|
AMP
|
0
|
BOX
|
LDP
|
LABDHI PHARMA
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
1204
|
PARASYMPATHOMIMETIC (CHOLINERGIC) AGENTS
|
2024-04-01
|
2026-03-31
|
|
IV
|
0
|
PARASYMPATHOMIMETIC (CHOLINERGIC) AGENTS
|
|
|
|
|
40
|
0741K
|
BENCOGEN 2MG TAB (LDP/AHI) BENZTROPINE
|
BENZTROPINE
|
BENCOGEN
|
1000'S
|
A
|
77.64
|
0.08
|
TABLET
|
90
|
TAB
|
LDP
|
LABDHI PHARMA
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
283608
|
ANTICHOLINERGIC AGENTS (PARKINSONS)
|
2022-04-01
|
2024-03-31
|
|
Oral
|
6
|
CENTRAL NERVOUS SYSTEM DRUGS
|
|
|
|
|
42
|
0741M
|
BENZTROPINE 2MG TAB (LAB)
|
BENZTROPINE
|
BENZTROPINE
|
1000'S
|
A
|
68.37
|
0.07
|
TAB
|
90
|
BOTT
|
LDP
|
LABDHI PHARMA
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
283608
|
ANTICHOLINERGIC AGENTS (PARKINSONS)
|
2026-04-01
|
|
|
ORAL
|
6
|
ANTICHOLINERGIC AGENTS (PARKINSONS)
|
|
|
|
|
41
|
0861H
|
LADRELINE 1MG/ML INJ (LDP) NORADRENALINE (BQ)
|
NORADRENALINE
|
LADRELINE
|
5X4ML
|
BQ
|
14.19
|
2.8379
|
AMP
|
0
|
BOX
|
LDP
|
LABDHI PHARMA
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
121212
|
ALPHA & BETA ADRENERGIC AGONIST
|
2024-04-01
|
2026-03-31
|
|
IV/IM
|
0
|
ALPHA & BETA ADRENERGIC AGONIST
|
|
|
|
|
41
|
0951N
|
LASULINE PLUS 50MG/ML INJ (LDP) SUXAMETHONIUM
|
SUXAMETHONIUM
|
LASULINE
|
10X10ML
|
B
|
133.74
|
13.3742
|
VIAL
|
100
|
BOX
|
LDP
|
LABDHI PHARMA
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
122020
|
NEUROMUSCULAR BLOCKING AGENTS
|
2024-04-01
|
2026-03-31
|
|
IV/IM
|
0
|
NEUROMUSCULAR BLOCKING AGENTS
|
|
|
|
|
40
|
1074S
|
DIGOXIN 0.25MG/ML INJ (LDP/AHI)
|
DIGOXIN
|
DIGOXIN
|
10X2ML
|
B
|
19.16
|
1.92
|
INJECTION
|
0
|
AMP
|
LDP
|
LABDHI PHARMA
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
24040492
|
CARDIAC GLYCOSIDES
|
2022-04-01
|
2024-03-31
|
|
IV
|
0
|
CARDIOVASCULAR DRUGS
|
|
|
|
|
41
|
1161AA
|
HYDRALLAZINE 25MG TAB (LDP)
|
HYDRALLAZINE
|
HYDRALLAZINE
|
250'S
|
A
|
14.87
|
0.0595
|
TAB
|
120
|
BOTT
|
LDP
|
LABDHI PHARMA
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
B
|
240820
|
DIRECT VASODILATOR
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
6
|
DIRECT VASODILATOR
|
|
|
|
|
40
|
1163J
|
LAHYZINE 20MG/ML INJ (LDP/AHI) HYDRALLAZINE
|
HYDRALLAZINE
|
LAHYZINE
|
20MG VIAL
|
B
|
5.71
|
5.71
|
INJECTION
|
0
|
VIAL
|
LDP
|
LABDHI PHARMA
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
240820
|
DIRECT VASODILATOR
|
2022-04-01
|
2024-03-31
|
|
IV
|
0
|
CARDIOVASCULAR DRUGS
|
|
